A new commercial low-density microarray which identifies common extended-spectrum ␤-lactamase plasmid-mediated cephalosporinase genes, as well as carbapenemase (bla KPC and bla NDM ) genes, was evaluated. We tested 207 clinical and reference/collection isolates of the Enterobacteriaceae possessing different bla genes. Overall, the sensitivity and specificity of the microarray were 100% for the detection of the plasmid-mediated bla AmpC , bla KPC , and bla NDM genes using bla gene sequencing as the reference method.
Resistance to ␤-lactams, including carbapenems, is rapidly spreading and is related to the worldwide dissemination of genes encoding extended-spectrum ␤-lactamases (ESBLs), carbapenemases, and plasmid-mediated AmpC ␤-lactamases (pAmpCs) (3, 8) . Class C cephalosporinases (AmpCs), which belong to group 1 ␤-lactamases (4), are encoded primarily in the chromosome of many species of the Enterobacteriaceae and confer resistance to penicillins, cephalosporins (narrow and extended spectrum), cephamycins (cefoxitin and cefotetan), and monobactams (aztreonam). Moreover, when associated with outer membrane protein (OMP) or porin deficiencies, AmpC ␤-lactamase overproduction can also confer resistance to carbapenems (9, 13) .
Plasmid-mediated bla AmpC ␤-lactamases (pAmpC) are now increasingly reported worldwide (7, 12, 15, 16) and are categorized into six groups: (i) the CMY-2 group, (ii) the MIR-1 and ACT-1 group, (iii) the DHA group, (iv) a fourth group represented by ACC-1, and two clusters represented by (v) CMY-1 (also called MOX-1) and (vi) FOX-1. These various pAmpCs likely escaped from the chromosome of natural AmpC-producing species of the Enterobacteriaceae (7).
Only molecular techniques are able to confirm the presence of pAmpC ␤-lactamases, which is of particular importance for epidemiological purposes and for the reporting of cephalosporin susceptibility testing (17) .
In the present study, we tested the Check-Points ESBL/ AmpC/KPC/NDM-1 assay (Check-MDR CT101; Check-Points B.V., Wageningen, The Netherlands). In comparison to the former ESBL-KPC array (Check-KPC ESBL) recently evaluated (5, 6, 10) , the present array targets 6 additional groups of pAmpC genes and the bla NDM-1 metallo-␤-lactamase gene (Fig. 1) . The system was evaluated in parallel at three centers, in Yvoir (Belgium), in Cleveland (Ohio), and in Paris (France).
A total of 207 isolates of the Enterobacteriaceae (200 clinical isolates from 3 different geographic origins, 1 nontransformed Escherichia coli isolate, DH10B, 5 E. coli DH10B isolates expressing cloned bla AmpC genes, and 1 Klebsiella pneumoniae isolate, ATCC 700603, expressing SHV-18) possessing different bla genes were included. Species identification was carried out using matrix-assisted laser desorption ionization-time-offlight (MALDI-TOF) mass spectrometry on a Microflex LT (Bruker Daltonics) or Microscan (Siemens) instrument or by using a Vitek2 system (bioMérieux). These strains had been well characterized or were characterized for this study with respect to their bla genes by PCR amplification and standard DNA sequencing as previously described (1, 2, 6, 10, 14) (Tables 1 and 2) or by PCR sequencing using an external sequencing service (Macrogen Inc., Seoul, South Korea). This collection included 24 chromosomal bla AmpC -producing isolates of the Enterobacteriaceae (Table 2) known to carry the progenitors of pAmpCs. These bla AmpC -producing members of the Enterobacteriaceae were screened in order to evaluate the reactivities of the probes targeting the pAmpC genes versus their chromosomal progenitors.
The whole microarray detection process requires 7 h of effort and was performed according to the manufacturer's instructions. In brief, whole-cell DNA was purified from 0.5 McFarland bacterial suspension using the EasyMag system (bioMérieux) or the DNeasy blood and tissue kit (Qiagen) (45 min). Twenty to forty nanograms of the DNA extract was used for a first ligation step (150 min), followed by a PCR amplification step (90 min). PCR products were then hybridized to the array and colorimetrically revealed (90 min). The results were read in a single-channel ATR03 array tube reader (Alere, Cologne, Germany) and automatically interpreted by the software provided by the manufacturer (15 min).
Using the Check-MDR CT101 assay, all the bla AmpC genes were correctly detected in all 87 pAmpC-producing isolates tested (Table 1) . When testing the array against 24 chromosomally encoded AmpC-producing isolates of the Enterobacteriaceae and one E. coli isolate in which chromosomal AmpC of Enterobacter cloacae P99 (E. coli P99) was cloned (Table 2) , we observed that the microarray did frequently detect the bla AmpC progenitor. In particular, the bla CMY-2 gene was detected in 4 out of 10 Citrobacter freundii isolates, bla ACT/MIR was identified in 5 out of 7 E. cloacae/Enterobacter asburiae isolates and in E. coli P99, bla DHA was detected in all four Morganella morganii isolates and bla ACC in 1 out of 2 Hafnia alvei isolates, but bla CMY-1 was not detected in Aeromonas hydrophila. Hence, we recommend identifying clinical isolates to the species level before testing them on the array in order to ensure the accuracy of plasmid-carried bla AmpC detection. Provided that the test was not performed on chromosomally encoded AmpC-producing species, specificities, sensitivities, and positive and negative predictive values of 100% were recorded for representative isolates of the six plasmid-carried bla AmpC gene families tested.
Regarding carbapenemases, KPC (K. pneumoniae [n ϭ 12], E. coli [n ϭ 3], and C. freundii [n ϭ 1]; not shown) and NDM-1 (K. pneumoniae [n ϭ 13], E. coli [n ϭ 2], including 10 concomitantly harboring pAmpC genes; Table 1 ) were correctly detected in all 31 strains tested (100% sensitivity and specificity), underscoring the ability of the Check-MDR CT101 array to detect some of the most worrisome carbapenemase genes recovered in the Enterobacteriaceae. We did not observe falsepositive results.
Regarding detection of bla ESBL genes, contrary to the case with the former ESBL array, when bla TEM or bla SHV nonESBLs are simultaneously present with a second bla TEM or bla SHV ESBL variant, respectively, the new array reports only the presence of the bla ESBL , ignoring the wild-type gene. Our results (not shown) confirmed those previously published (6, 10), with 100% specificity for the detection of bla TEM, bla SHV , and bla -CTX-M genes (94 bla TEM non-ESBL genes and 17 bla TEM-ESBL, 52 bla SHV non-ESBL or bla LEN , 24 bla SHV-ESBL , and 41 bla CTX-M genes) and a sensitivity varying between 92% for bla SHV non-ESBL or bla LEN (principally due to the lack of detection of bla LEN ), 96% for bla SHV-ESBL (bla SHV-38 is not detected by the array [10] ), and 100% for the bla TEM-ESBL , bla TEM non-ESBL , and bla CTX-M genes.
Owing to its rapid and precise analytical performance, this platform appears well suited for use in epidemiological or infection control studies in which large collections of isolates require characterization. The fact that multiple resistance genes were correctly identified whatever the complex genetic background of the tested isolates (presence of multiple ESBL genes and of the bla NDM-1 or bla KPC gene in addition to the various bla AmpC genes) confirms that the Check-Points array technology is a highly accurate tool for detection of coexistent bla genes. Use of this technology on a routine basis is still hampered by the low prevalence of pAmpC-and carbapenemase-producing isolates in most countries and by the length of the detection process (7 h). However, the system was shown to be flexible and clinically responsive since new important targets . c Includes DHA-1 (n ϭ 6), DHA-2 (n ϭ 2), and DHA-7 (n ϭ 1). d Includes FOX-3 (n ϭ 1) and FOX-5 (n ϭ 6). e Includes MIR-1 (n ϭ 1) and ACT-1 (n ϭ 2). f Includes CMY-1 (n ϭ 1) and CMY-10 (n ϭ 2). g Includes Citrobacter koseri (n ϭ 2), Serratia marcescens (n ϭ 2), Citrobacter braakii (n ϭ 1), and Providencia stuartii (n ϭ 1). h Results obtained with PCR/sequencing. i Results obtained with the Check-MDR CT101 microarray. j One hundred percent agreement between the two methods for all gene groups. For all pAmpC-and NDM-1-producing isolates: sensitivity, 100%; specificity, 100%; positive and negative predictive value, 100%. k Fifteen isolates concomitantly harboring CTX-M-15, 14 harboring TEM-1, 11 harboring non-ESBL SHV, 1 harboring SHV-12, and 10 harboring pAmpC (CMY-2-like) genes.
were rapidly incorporated into the assay by the manufacturer. We anticipate that additional targets, such as oxacillinase-coding genes and, especially for nonfermenters, minor ESBLs (BEL, VEB, PER, and GES) (11) and OXA-carbapenemases could readily be added and validated whenever the need arises. We thank Check-Points for providing the material necessary for the study and Aneta Karczmarek for technical support. Citrobacter freundii (CMY- 
